终末期肝病与肌少症的关系

李侗曾; 孔明; 陈煜

doi:10.3969/j.issn.1001-5256.2020.03.050

终末期肝病与肌少症的关系

DOI: 10.3969/j.issn.1001-5256.2020.03.050

首都医科大学附属北京佑安医院肝衰竭与人工肝治疗研究北京市重点实验室

基金项目:

国家科技重大专项“艾滋病和病毒性肝炎等重大传染病防治”(2017ZX10203201-005)；北京市医院管理局临床医学发展专项经费资助(ZYLX201806);北京市医院管理局消化内科学科协同发展中心项目(XXZ0503);北京市医院管理局“登峰”人才培养计划基金资助项目(DFL20151601)；

详细信息

中图分类号: R575.3
计量
- 文章访问数: 922
- HTML全文浏览量: 43
- PDF下载量: 227
- 被引次数: 0
出版历程
- 收稿日期: 2019-10-12
- 出版日期: 2020-03-20

Association between end-stage liver disease and sarcopenia

Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research,Beijing YouAn Hospital,Capital Medical University

Research funding:

摘要

摘要: 终末期肝病往往伴发各种并发症,其中肌少症是终末期肝病患者的常见并发症,但是容易被临床医生忽略,实际上肌少症也会影响终末期肝病患者的预后。阐述了肌少症的定义及评估方法、诊断标准,及其与多种终末期肝病的关系,认为应深入探究肌少症在肝病发展中的作用,为肝脏疾病的诊治提供新思路。
- 终末期肝病 /
- 肌肉衰减征 /
- 诊断 /
- 治疗学
Abstract: End-stage liver disease is often accompanied by various complications,among which sarcopenia is a common complication in patients with end-stage liver disease and is often neglected by clinicians,and in fact,sarcopenia also affects the prognosis of patients with end-stage liver disease. This article elaborates on the definition,evaluation method,and diagnostic criteria for sarcopenia and the association of sarcopenia with various liver diseases. It is pointed out that further studies are needed to explore the role of sarcopenia in the development of liver diseases,so as to provide new ideas for the diagnosis and treatment of liver diseases.
- end stage liver disease /
- sarcopenia /
- diagnosis /
- therapeutics

HTML全文

参考文献(40)

[1] Chinese Society of Hepatology,Chinese Society of Gastroenterology,Chinese Medical Association. Clinical guidelines on nutrition in end-stage liver disease[J]. J Clin Hepatol,2019,35(6):1222-1230.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会．终末期肝病临床营养指南[J]．临床肝胆病杂志，2019,35(6):1222-1230.

[2] MONTANO-LOZA AJ. Clinical relevance of sarcopenia in patients with cirrhosis[J]. World J Gastroenterol,2014,20(25):8061-8071.

[3] TRUSWELL AS. Standardization of nomenclature of body composition in weight loss[J]. Am J Clin Nutr,1998,67(3):492-493.

[4] JONES SE,MADDOCKS M,KON SS,et al. Sarcopenia in COPD:Prevalence,clinical correlates and response to pulmonary rehabilitation[J]. Thorax,2015,70(3):213-218.

[5] de BLASIO F,di GREGORIO A,de BLASIO F,et al. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria,and evaluation of raw BIA variables[J]. Respir Med,2018,134:1-5.

[6] SINCLAIR M,GOW PJ,GROSSMANN M,et al. Review article:Sarcopenia in cirrhosis—aetiology,implications and potential therapeutic interventions[J]. Aliment Pharmacol Ther,2016,43(7):765-777.

[7] DASARATHY S,MERLI M. Sarcopenia from mechanism to diagnosis and treatment in liver disease[J]. J Hepatol,2016,65(6):1232-1244.

[8] KIM G,KANG SH,KIM MY,et al. Prognostic value of sarcopenia in patients with liver cirrhosis:A systematic review and meta-analysis[J]. PLo S One,2017,12(10):e0186990.

[9] CRUZ-JENTOFT AJ,BAEYENS JP,BAUER JM,et al. Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing,2010,39(4):412-423.

[10] FIELDING RA,VELLAS B,EVANS WJ,et al. Sarcopenia:An undiagnosed condition in older adults. Current consensus definition:Prevalence,etiology,and consequences. International working group on sarcopenia[J]. J Am Med Dir Assoc,2011,12(4):249-256.

[11] CHEN LK,LIU LK,WOO J,et al. Sarcopenia in Asia:Consensus report of the Asian Working Group for Sarcopenia[J].J Am Med Dir Assoc,2014,15(2):95-101.

[12] PENG TC,WU LW,CHEN WL,et al. Nonalcoholic fatty liver disease and sarcopenia in a Western population(NHANES III):The importance of sarcopenia definition[J]. Clin Nutr,2019,38(1):422-428.

[13] MENG NH,LI CI,LIU CS,et al. Comparison of height-and weight-adjusted sarcopenia in a Taiwanese metropolitan older population[J]. Geriatr Gerontol Int,2015,15(1):45-53.

[14] SHEN W,PUNYANITYA M,WANG Z,et al. Total body skeletal muscle and adipose tissue volumes:Estimation from a single abdominal cross-sectional image[J]. J Appl Physiol(1985),2004,97(6):2333-2338.

[15] CAREY EJ,LAI JC,WANG CW,et al. A multicenter study to define sarcopenia in patients with end-stage liver disease[J]. Liver Transpl,2017,23(5):625-633.

[16] CRUZ-JENTOFT AJ,BAHAT G,BAUER J,et al. Sarcopenia:Revised European consensus on definition and diagnosis[J]. Age Ageing,2019,48(4):601.

[17] European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease[J]. J Hepatol,2019,70(1):172-193.

[18] MONTANO-LOZA AJ,MEZA-JUNCO J,PRADO CM,et al.Muscle wasting is associated with mortality in patients with cirrhosis[J]. Clin Gastroenterol Hepatol,2012,10(2):166-173.

[19] TANDON P,NEY M,IRWIN I,et al. Severe muscle depletion in patients on the liver transplant wait list:Its prevalence and independent prognostic value[J]. Liver Transpl,2012,18(10):1209-1216.

[20] DURAND F,BUYSE S,FRANCOZ C,et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography[J]. J Hepatol,2014,60(6):1151-1157.

[21] HANAI T,SHIRAKI M,NISHIMURA K,et al. Sarcopenia impairs prognosis of patients with liver cirrhosis[J]. Nutrition,2015,31(1):193-199.

[22] KALAFATELI M,MANTZOUKIS K,CHOI YY,et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score[J]. J Cachexia Sarcopenia Muscle,2017,8(1):113-121.

[23] KUO SZ,AHMAD M,DUNN MA,et al. Sarcopenia predicts posttransplant mortality in acutely ill men undergoing urgent evaluation and liver transplantation[J]. Transplantation,2019.[Epub ahead of print]

[24] MERLI M,GIUSTO M,LUCIDI C,et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy:Results of a prospective study[J]. Metab Brain Dis,2013,28(2):281-284.

[25] HARA N,IWASA M,SUGIMOTO R,et al. Sarcopenia and sarcopenic obesity are prognostic factors for overall survival in patients with cirrhosis[J]. Intern Med,2016,55(8):863-870.

[26] MONTANO-LOZA AJ,ANGULO P,MEZA-JUNCO J,et al.Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis[J]. J Cachexia Sarcopenia Muscle,2016,7(2):126-135.

[27] QUIGLEY EM,STANTON C,MURPHY EF. The gut microbiota and the liver. Pathophysiological and clinical implications[J].J Hepatol,2013,58(5):1020-1027.

[28] TSIEN C,DAVULURI G,SINGH D,et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis[J]. Hepatology,2015,61(6):2018-2029.

[29] SINCLAIR M,GROSSMANN M,HOERMANN R,et al. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone:A randomised controlled trial[J]. J Hepatol,2016,65(5):906-913.

[30] CHEN HW,DUNN MA. Muscle at risk:The multiple impacts of ammonia on sarcopenia and frailty in cirrhosis[J]. Clin Transl Gastroenterol,2016,7:e170.

[31] GARCÍA PS,CABBABE A,KAMBADUR R,et al. Brief-reports:Elevated myostatin levels in patients with liver disease:A potential contributor to skeletal muscle wasting[J]. Anesth Analg,2010,111(3):707-709.

[32] QIU J,TSIEN C,THAPALAYA S,et al. Hyperammonemiamediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis[J]. Am J Physiol Endocrinol Metab,2012,303(8):e983-e993.

[33] DASARATHY J,MCCULLOUGH AJ,DASARATHY S. Sarcopenia in alcoholic liver disease:Clinical and molecular advances[J].Alcohol Clin Exp Res,2017,41(8):1419-1431.

[34] HAYASHI F,MATSUMOTO Y,MOMOKI C,et al. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis[J]. Hepatol Res,2013,43(12):1264-1275.

[35] DUAN ZP. Nutrition of patients with liver diseases:What is the highlight[J]. J Pract Hepatol,2014,17(5):449-451.(in Chinese)段钟平．肝病营养问题再关注[J]．实用肝脏病杂志，2014,17(5):449-451.

[36] PLAUTH M,BERNAL W,DASARATHY S,et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr,2019,38(2):485-521.

[37] KAIDO T,OGAWA K,FUJIMOTO Y,et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation[J]. Am J Transplant,2013,13(6):1549-1556.

[38] NASEER M,TURSE EP,SYED A,et al. Interventions to improve sarcopenia in cirrhosis:A systematic review[J]. World J Clin Cases,2019,7(2):156-170.

[39] ROMÁN E,TORRADES MT,NADAL MJ,et al. Randomized pilot study:Effects of an exercise programme and leucine supplementation in patients with cirrhosis[J]. Dig Dis Sci,2014,59(8):1966-1975.

[40] YURCI A,YUCESOY M,UNLUHIZARCI K,et al. Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis[J]. Clin Res Hepatol Gastroenterol,2011,35(12):845-854.

施引文献

资源附件(0)

访问统计